Find a Study

STUDY SEARCH RESULTS
  Notify Me When Search is Updated

9 studies found for your search request:  molnupiravir

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) ...
Condition: Coronavirus Disease (COVID-19)
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06667700
Status: Recruiting
Has Enrolling Locations in US or Canada

A Study to Evaluate Molnupiravir (MK-4482) in Participants with Moderate Hepatic Impairment (MK-4482...
Condition: Hepatic Impairment
Minimum Age: 18 years, Maximum Age: 75 years
Gender: All
Study ID: NCT05386589
Status: Completed
Has Results

A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants with Severe Renal Impairment (MK-448...
Condition: Renal Impairment
Minimum Age: 18 years, Maximum Age: 75 years
Gender: All
Study ID: NCT05386758
Status: Completed
Has Results

A Study to Evaluate Molnupiravir Tablet Formulation Compared to the Molnupiravir Capsule Formulation...
Condition: Healthy
Minimum Age: 18 years, Maximum Age: 60 years
Gender: All
Study ID: NCT06615869
Status: Completed

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants with COVID-19 (MK-4...
Condition: Coronavirus Disease (COVID-19)
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04575584
Status: Terminated (Halted Prematurely)



Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site

Accessibility icon